SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-004724
Filing Date
2024-02-20
Accepted
2024-02-20 08:00:15
Documents
17
Period of Report
2024-02-20
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20240216_8k.htm   iXBRL 8-K 25304
2 EXHIBIT 99.1 ex_627936.htm EX-99.1 10194
7 monologo.jpg GRAPHIC 3641
  Complete submission text file 0001437749-24-004724.txt   183670

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20240220.xsd EX-101.SCH 3410
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20240220_def.xml EX-101.DEF 12188
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20240220_lab.xml EX-101.LAB 16397
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20240220_pre.xml EX-101.PRE 12458
18 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20240216_8k_htm.xml XML 3057
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 24650787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)